- 英文名称
- 6,11-Di-O-Methyl Erythromycin
- 分子式
- C39H71NO13
- 分子量
- 761.98
- 中文别名
- 克拉霉素杂质5; 克拉霉素杂质E; 克拉霉素EP杂质E; 克拉霉素杂质E(EP); 克拉霉素相关化合物A(USP); 克拉红霉素EP杂质E; 克拉霉素USP相关化合物A; 克拉霉素杂质05; (3R,4S,5S,6R,7R,9R,11R,12R,13R,14R)-6-((2S,3R,4S,6R)-4-(二甲氨基)-3-羟基-6-甲基四氢-2H-吡喃-2-基)氧基)-14-乙基-13-羟基-4-((2R,4R,5S,6S)-5-羟基-4-甲氧基-4,6-二甲基四氢-2H-吡喃-2-基)氧基)-7,12-二甲氧基-3,5,7,9,11,13-六甲基氧基克洛特拉糖-2,10-二酮; 11-O-Methylclarithromycin; Clarithromycin Impurity 5; Clarithromycin EP Impurity E; Clarithromycin Related Compound A; Erythromycin, 6,11-di-O-methyl-; 6-((4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-13-hydroxy-4-((5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-7,12-dimethoxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione; (3R,4S,5S,6R,7R,9R,11R,12R,13R,14R)-6-{[(2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-13-hydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-7,12-dimethoxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione
- 用途
- 医药分析标准。
